|
GBF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.19310000004747E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.66350000055482E-07 |
| Normal-vs-Stage2 |
1.502940E-03 |
| Normal-vs-Stage3 |
8.200200E-03 |
| Normal-vs-Stage4 |
6.108000E-02 |
| Stage1-vs-Stage2 |
6.817000E-01 |
| Stage1-vs-Stage3 |
4.430000E-01 |
| Stage1-vs-Stage4 |
9.684200E-01 |
| Stage2-vs-Stage3 |
8.331200E-01 |
| Stage2-vs-Stage4 |
7.942000E-01 |
| Stage3-vs-Stage4 |
6.934400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.31949999995873E-06 |
| Normal-vs-AfricanAmerican |
5.81589999999466E-05 |
| Normal-vs-Asian |
9.818200E-03 |
| Caucasian-vs-AfricanAmerican |
8.367200E-01 |
| Caucasian-vs-Asian |
6.050600E-01 |
| AfricanAmerican-vs-Asian |
6.264000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.14089999956069E-07 |
| Normal-vs-Female |
3.377500E-02 |
| Male-vs-Female |
3.877200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.38149999999271E-05 |
| Normal-vs-Extreme_Weight |
5.17499999963533E-07 |
| Normal-vs-Obese |
2.355200E-03 |
| Normal-vs-Extreme_Obese |
8.175200E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.646000E-01 |
| Normal_Weight-vs-Obese |
1.256630E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.886800E-01 |
| Extreme_Weight-vs-Obese |
2.506000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.854000E-01 |
| Obese-vs-Extreme_Obese |
2.889800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.618800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.753900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.08389999997627E-06 |
| Normal-vs-Age(81-100Yrs) |
4.72900000048071E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.781600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.702000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.202200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.474400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.472110E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.026160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.87499999999763E-05 |
| Normal-VS-Type2 PRCC |
1.07510000013633E-07 |
| Normal-VS-KIRP CIMP |
8.692200E-01 |
| Normal-VS-Unclassified PRCC |
2.175200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.874190E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.193200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.395670E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.583700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.209500E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
6.465800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.04480000393681E-08 |
| Normal-vs-N1 |
6.746000E-02 |
| Normal-vs-N2 |
3.672200E-01 |
| N0-vs-N1 |
1.286650E-01 |
| N0-vs-N2 |
1.631850E-01 |
| N1-vs-N2 |
8.296000E-01 |
|
|
